132 related articles for article (PubMed ID: 9832969)
1. CCK receptor antagonists in animal models of anxiety: comparison between exploration tests, conflict procedures and a model based on defensive behaviours.
Griebel G; Perrault G; Sanger DJ
Behav Pharmacol; 1997 Nov; 8(6-7):549-60. PubMed ID: 9832969
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.
Griebel G; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1998 Jul; 138(1):55-66. PubMed ID: 9694527
[TBL] [Abstract][Full Text] [Related]
3. Failure of CCK receptor ligands to modify anxiety-related behavioural suppression in an operant conflict paradigm in rats.
Charrier D; Dangoumau L; Puech AJ; Hamon M; Thiébot MH
Psychopharmacology (Berl); 1995 Sep; 121(1):127-34. PubMed ID: 8539337
[TBL] [Abstract][Full Text] [Related]
4. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
5. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Griebel G; Perrault G; Sanger DJ
J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
[TBL] [Abstract][Full Text] [Related]
6. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
Griebel G; Rodgers RJ; Perrault G; Sanger DJ
Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
[TBL] [Abstract][Full Text] [Related]
7. Effects of SR48968, a selective non-peptide NK2 receptor antagonist on emotional processes in rodents.
Griebel G; Perrault G; Soubrié P
Psychopharmacology (Berl); 2001 Nov; 158(3):241-51. PubMed ID: 11713613
[TBL] [Abstract][Full Text] [Related]
8. Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists.
Griebel G; Rodgers RJ; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1999 May; 144(2):121-30. PubMed ID: 10394992
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety.
Griebel G; Perrault G; Sanger DJ
Neuropharmacology; 1997 Jun; 36(6):793-802. PubMed ID: 9225307
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies on synthetic flavonoids: comparison with diazepam.
Griebel G; Perrault G; Tan S; Schoemaker H; Sanger DJ
Neuropharmacology; 1999 Jul; 38(7):965-77. PubMed ID: 10428415
[TBL] [Abstract][Full Text] [Related]
11. Exploratory behavior models of anxiety in mice.
Crawley JN
Neurosci Biobehav Rev; 1985; 9(1):37-44. PubMed ID: 2858080
[TBL] [Abstract][Full Text] [Related]
12. The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice.
Hendrie CA; Neill JC; Shepherd JK; Dourish CT
Physiol Behav; 1993 Oct; 54(4):689-93. PubMed ID: 7902586
[TBL] [Abstract][Full Text] [Related]
13. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
[TBL] [Abstract][Full Text] [Related]
15. The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.
Chopin P; Briley M
Psychopharmacology (Berl); 1993; 110(4):409-14. PubMed ID: 7870910
[TBL] [Abstract][Full Text] [Related]
16. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat.
Matto V; Harro J; Allikmets L
Neuropharmacology; 1997 Mar; 36(3):389-96. PubMed ID: 9175618
[TBL] [Abstract][Full Text] [Related]
17. ADN-1184, a monoaminergic ligand with 5-HT6/7 receptor antagonist action, exhibits activity in animal models of anxiety.
Partyka A; Wasik A; Jastrzębska-Więsek M; Mierzejewski P; Bieńkowski P; Kołaczkowski M; Wesołowska A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):593-602. PubMed ID: 26979176
[TBL] [Abstract][Full Text] [Related]
18. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of diazepam and NK1 receptor antagonists in two conflict procedures in rats.
Loiseau F; Le Bihan C; Hamon M; Thiébot MH
Behav Pharmacol; 2003 Sep; 14(5-6):447-55. PubMed ID: 14501257
[TBL] [Abstract][Full Text] [Related]
20. Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.
Johnson NJ; Rodgers RJ
Psychopharmacology (Berl); 1996 Apr; 124(4):355-64. PubMed ID: 8739551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
